A Supramolecular Assembly of EGCG for Long-Term Treatment of Allergic Rhinitis
- 25 March 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (4) , 2282-2298
Abstract
Allergic rhinitis (AR) is a type-I hypersensitivity disease mediated by immunoglobulin E (IgE). Although antihistamines, glucocorticoids, leukotriene receptor antagonists, and other drugs are widely used to treat AR, the various adverse side effects of long-term use of these drugs should not be ignored. Therefore, more effective and safe natural alternative strategies are urgently needed. To this end, this study designed a nanosupramolecular delivery system composed of β-cyclodextrin supramolecular polymer (PCD), thiolated chitosan (TCS), and natural polyphenol epigallocatechin gallate (EGCG) for intranasal topical continuous treatment of AR. The TCS/PCD@EGCG nanocarriers exhibited an excellent performance in terms of retention and permeability in the nasal mucosa and released the vast majority of EGCG responsively in the nasal microenvironment, thus resulting in the significantly high antibacterial and antioxidant capacities. According to the in vitro model, compared with free EGCG, TCS/PCD@EGCG inhibited mast cell activity and abnormal histamine secretion in a more long-term and sustained manner. According to the in vivo model, whether in the presence of continuous or intermittent administration, TCS/PCD@EGCG substantially inhibited the secretion of allergenic factors and inflammatory factors, mitigated the pathological changes of nasal mucosa, alleviated the symptoms of rhinitis in mice, and produced a satisfactory therapeutic effect on AR. In particular, the therapeutic effect of TCS/PCD@EGCG systems were even superior to that of budesonide during intermittent treatment. Therefore, the TCS/PCD@EGCG nanocarrier is a potential long-lasting antiallergic medicine for the treatment of AR.Keywords
Funding Information
- National Natural Science Foundation of China (22277119, 52273107)
This publication has 79 references indexed in Scilit:
- Supramolecular nanomedicines based on host–guest interactions of cyclodextrinsExploration, 2023
- Polyphenol‐Based Assembly Nanosystems as Multifunctional Biopharmaceutical PlatformAdvanced NanoBiomed Research, 2023
- International consensus statement on allergy and rhinology: Allergic rhinitis – 2023International Forum of Allergy & Rhinology, 2023
- Direct nose to the brain nanomedicine delivery presents a formidable challengeWIREs Nanomedicine and Nanobiotechnology, 2021
- The amendatory effect of hesperidin and thymol in allergic rhinitis: an ovalbumin-induced rat modelEuropean Archives of Oto-Rhino-Laryngology, 2018
- Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine deliveryArchives of Pharmacal Research, 2016
- Subsequent risk of nasopharyngeal carcinoma among patients with allergic rhinitis: A nationwide population-based cohort studyHead & Neck, 2014
- NMR and molecular fluorescence spectroscopic study of the structure and thermodynamic parameters of EGCG/β-cyclodextrin inclusion complexes with potential antioxidant activityJournal of Inclusion Phenomena and Macrocyclic Chemistry, 2013
- Relationships between atopy and bacterial infectionsCurrent Allergy and Asthma Reports, 2003
- A procedure to measure the antiradical efficiency of polyphenolsJournal of the Science of Food and Agriculture, 1998